Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 27Neoplasms 20Cancer Pain 10Colonic Neoplasms 7Breakthrough Pain 7Agnosia 7Breast Neoplasms 5Rectal Neoplasms 4Prostatic Neoplasms 4Lung Neoplasms 4Head and Neck Neoplasms 4Chronic Pain 4Urinary Bladder Neoplasms 3Sarcoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Pain, Postoperative 3Lymphoma, Follicular 3Breakthrough Cancer Pain 3Waldenstrom Macroglobulinemia 2Uterine Cervical Neoplasms 2Thrombocythemia, Essential 2Sezary Syndrome 2Primary Myelofibrosis 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Polycythemia Vera 2Pleural Effusion, Malignant 2Pdgfra-Associated Chronic Eosinophilic Leukemia 2Myeloproliferative Disorders 2Mycosis Fungoides 2

Interventions

Transplantation, Homologous 1Transplantation, Autologous 1Fentanyl 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Failed Back Surgery Syndrome × Fentanyl × Clear all
NCT03523000 2023-01-12

Determining the Prognostic Value of Continuous Intrathecal Infusion

University Hospitals Cleveland Medical Center

Phase 4 Completed
36 enrolled 14 charts

post laminectomy syndrome, Failed Back Surgery Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡